Adults with mild-moderate persistent asthma who did not receive ICS for 3 months were randomized to MF 400 g once daily ( QD ) in the evening ( pm ) , MF 200 g QD pm , montelukast sodium ( ML ) 10 mg QD pm , or fluticasone propionate ( FP ) 250 g twice daily .